Painful Diabetic Neuropathies Terminated Phase 2 Trials for Olodanrigan (DB16266)

Also known as: Painful Diabetic Neuropathy / Diabetic Neuropathies, Painful / Painful Diabetic Neuropathy (PDN) / Diabetic Neuropathy, Painful; Diabetic Neuropathies / Diabetic Neuropathy, Painful

IndicationStatusPhase
DBCOND0055434 (Painful Diabetic Neuropathies)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03297294Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy (PDN)Treatment